Core Points - The company is set to list 16,314,684 shares of restricted stock for trading on July 25, 2025, following its initial public offering [1][2] - The restricted shares represent 2.82% of the company's total share capital of 575,000,000 shares [2][4] - The lock-up period for these shares is 36 months from the date of the company's initial public offering [2][4] Summary by Sections Type of Restricted Shares - The restricted shares are part of the company's initial public offering and will be released for trading after a 36-month lock-up period [2][4] - The shares are held by three employee stockholding platforms [2] Changes in Share Capital - Since the formation of the restricted shares, the company has undergone changes in its share capital due to the granting of restricted stock under its incentive plan, totaling 3,327,844 shares [2] Commitments Related to Restricted Shares - The shareholders have committed not to transfer or manage the shares for 36 months following the IPO [3] - If the commitments are violated, the proceeds from any share sales will belong to the company [3] Verification by Intermediaries - The sponsor, CITIC Securities, has confirmed that the shareholders have adhered to their commitments regarding the restricted shares [3] Details of Restricted Shares - The total number of restricted shares being listed is 16,314,684, with a lock-up period of 36 months [4] - The listing date for these shares is July 25, 2025 [4] - The shareholders include Shanghai Yixi Enterprise Management Center, Shanghai Yimu Enterprise Management Center, and YAOLIN WANG LLC [4][5]
益方生物: 益方生物首次公开发行部分限售股上市流通公告